Ziyad Ayyoub to Humans
This is a "connection" page, showing publications Ziyad Ayyoub has written about Humans.
Connection Strength
0.284
-
Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA. Toxins (Basel). 2020 10 19; 12(10).
Score: 0.081
-
Imaging of Diffuse Neurosyphilis Affecting the Corticospinal Tracts and Cerebellum. PM R. 2020 03; 12(3):330-331.
Score: 0.077
-
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication. Toxins (Basel). 2024 Sep 29; 16(10).
Score: 0.026
-
Heterotopic ossification complicating prolonged intubation: case report and review of the literature. J Spinal Cord Med. 2002; 25(1):46-9.
Score: 0.022
-
AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol. Adv Ther. 2021 11; 38(11):5623-5633.
Score: 0.021
-
Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study. PM R. 2018 01; 10(1):1-10.
Score: 0.016
-
OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a?Delphi Panel Approach. PM R. 2017 Oct; 9(10):960-968.
Score: 0.016
-
OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process. PM R. 2017 02; 9(2):136-148.
Score: 0.015
-
Efficacy and safety study of arbaclofen placarbil in patients with spasticity due to spinal cord injury. Spinal Cord. 2011 Sep; 49(9):974-80.
Score: 0.010